The thing I don't understand is that the FDA do not award Qualified Infectious Disease Designation to potential IND's where testing did not comply with US GLP regulations, they most certainly do not waist their time with face to face meetings with drug companies presenting them with non compliant GLP material, also I do not see why constant reference to the IND acronym is so important when they are at the stage of talking to the FDA about Phase one Human trials because it is obvious that IND approval is needed to start those trials. IMO DYOR
- Forums
- ASX - By Stock
- RCE
- Ann: Update on meeting with US FDA
Ann: Update on meeting with US FDA, page-31
-
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RCE (ASX) to my watchlist
|
|||||
Last
54.5¢ |
Change
0.035(6.86%) |
Mkt cap ! $126.2M |
Open | High | Low | Value | Volume |
51.0¢ | 55.0¢ | 51.0¢ | $167.8K | 316.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 317 | 53.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
54.5¢ | 4099 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 317 | 0.535 |
1 | 4000 | 0.530 |
2 | 35000 | 0.525 |
1 | 12500 | 0.520 |
1 | 25000 | 0.515 |
Price($) | Vol. | No. |
---|---|---|
0.545 | 45 | 1 |
0.550 | 5054 | 2 |
0.555 | 10000 | 1 |
0.560 | 6785 | 3 |
0.570 | 44444 | 1 |
Last trade - 15.59pm 06/09/2024 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |